Milligan Michael Lee — SEC Form 4 filings
SEC reporting owner CIK 1993953. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-16 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 3,414 shares, $8,470 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 1,436 shares @ $3.56 ($5,119) in Neumora Therapeutics, Inc., filed 2026-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | See Remarks | 7 | — | 2 legs · 3,414 sh · $8,470 | 23 |
Form 4 filings — Milligan Michael Lee
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Neumora Therapeutics, Inc. (NMRA) | Sale (S): 1,436 @ $3.56 | EDGAR |
| 2026-01-09 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Neumora Therapeutics, Inc. (NMRA) | Disposition to issuer (D): 85,391 (derivative) · Disposition to issuer (D): 38,234 (derivative) · Disposition to issuer (D): 28,675 (derivative) · Disposition to issuer (D): 41,250 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Grant/award (A): 85,391 (derivative) · +4 more | EDGAR |
| 2025-02-20 | 4 | Neumora Therapeutics, Inc. (NMRA) | Sale (S): 1,978 @ $1.69 | EDGAR |
| 2025-02-18 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 400,000 (derivative) @ $0 · Disposition to issuer (D): 85,391 (derivative) · Disposition to issuer (D): 38,234 (derivative) · Disposition to issuer (D): 28,675 (derivative) · Disposition to issuer (D): 41,250 (derivative) · Grant/award (A): 85,391 (derivative) · +3 more | EDGAR |
| 2024-02-16 | 4 | Neumora Therapeutics, Inc. (NMRA) | Grant/award (A): 20,625 @ $0 · Grant/award (A): 41,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1993953 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →